This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Investors Should Hold on to MetLife Stock Right Now
by Zacks Equity Research
MET benefits from higher premiums and cost-cutting initiatives.
Why Is MetLife (MET) Down 1.7% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights MetLife, American International, Prudential Financial, Radian and CNO Financial
by Zacks Equity Research
MetLife, American International, Prudential Financial, Radian and CNO Financial have been highlighted in this Industry Outlook article.
5 Multiline Insurers to Watch as Competition Rises, Pricing Moderates
by Tanuka De
Better pricing, product redesigns, technological advancement and improving inflation are expected to aid multiline insurers like MET, AIG, PRU, RDN and CNO.
MetLife Q4 Earnings Miss Estimates on Weak RIS & EMEA Unit
by Zacks Equity Research
Management expects a variable investment income of $1.7 billion for 2025.
Compared to Estimates, MetLife (MET) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MetLife (MET) Misses Q4 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -2.35% and 2.65%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Invesco S&P 500 Equal Weight Financials ETF (RSPF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPF
What's in Store for These Three Insurance Stocks in Q4 Earnings?
by Debasmita Chatterjee
Insurers like ALL, MET and AFL are likely to have witnessed premium growth in Q4. Lower interest rates are expected to have pressured life insurers' returns, while M&A, tech investments and catastrophe impacts shaped industry trends.
Will Rising Expenses Dampen MetLife's Q4 Earnings Growth?
by Zacks Equity Research
MET's fourth-quarter earnings are expected to have been affected by higher expenses and lower net investment income.
Stay Ahead of the Game With MetLife (MET) Q4 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Evaluate the expected performance of MetLife (MET) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Principal Financial (PFG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Principal Financial (PFG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Assurant Stock Trading at Discount to Industry at 2.07X: Time to Buy?
by Zacks Equity Research
AIZ stock is poised to gain from a well-performing Global Lifestyle business, growth of fee-based capital-light businesses and effective capital deployment.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
MetLife Expands Asset Management With $6B Acquisition From Mesirow
by Zacks Equity Research
MetLife Investment Management boosts its portfolio with a $6B acquisition from Mesirow, adding high-yield strategies, small-cap equity expertise and 20 seasoned professionals to fuel growth.
Prudential Stock Slips Below 50-Day SMA: What Should You Do Now?
by Tanuka De
PRU is set to grow on solid asset-based businesses, international operations and deeper reach in pension risk transfer market.
Compelling Reasons for Investors to Hold on to MetLife Stock Right Now
by Zacks Equity Research
MET remains well-poised for growth, attributed to a well-performing Group Benefits segment, partnerships and a notable financial position.
MetLife's Asset Management Arm Expands Reach With PineBridge Buyout
by Zacks Equity Research
MET's asset management arm is expected to close the acquisition of PineBridge by 2025, expanding its offerings and global presence.
THG Stock Trades at a Premium to the Industry: What Should You Do Now?
by Tanuka De
THG stands to gain from growth in the Core Commercial and Specialty segments, stable retention, better pricing, strong market presence and solid capital position.
MetLife Collaborates With General Atlantic to Launch Chariot Re
by Zacks Equity Research
MET and General Atlantic partner to launch Chariot Re, a life and annuity reinsurance company, expanding their footprint in the reinsurance space.
MetLife Partners With Workday to Enhance Employer Benefit Programs
by Zacks Equity Research
MET collaborates with Workday to optimize employer benefit programs according to employee preferences.
AIG Stock Rises 12.1% YTD: Should Investors Hold or Fold?
by Zacks Equity Research
AIG's improving business mix, growing returns on investments and ongoing expense discipline position it well for long-term growth.
Hartford Financial Shares Near 52-Week High: How to Play the Stock
by Zacks Equity Research
HIG's balance sheet strength provides the financial flexibility to pursue growth initiatives and boost shareholder value.